RHO rs121912528: What Your Genotype Means
The rs121912528 variant in the RHO gene is a rare genetic change that results in a Pro23His amino acid substitution. This specific alteration is associated with autosomal dominant retinitis pigmentosa, a condition characterized by the progressive loss of vision.
What each genotype means
Typical rhodopsin function
This genotype represents the common, non-pathogenic sequence for this specific location in the RHO gene. It is not associated with the Pro23His substitution or the increased risk of autosomal dominant retinitis pigmentosa linked to this variant.
This is the most common genotype found in the general population globally.
Increased risk of retinal degeneration
This genotype indicates the presence of the Pro23His substitution, a pathogenic variant known to cause autosomal dominant retinitis pigmentosa. Individuals with this genotype may experience progressive night blindness and vision loss, and should consult with an ophthalmologist or genetic counselor regarding clinical monitoring.
This genotype is extremely rare globally, though it has been identified as a recurrent founder mutation in certain North American populations.
High risk of retinal degeneration
This genotype indicates the presence of two copies of the pathogenic Pro23His variant. While this condition is typically inherited in an autosomal dominant pattern, the presence of this variant is strongly associated with progressive retinal degeneration and vision loss; clinical evaluation by a specialist is recommended.
This genotype is exceptionally rare and is not typically observed in general population databases.
Understanding the rs121912528 Variant
The variant rs121912528, often referred to in clinical literature as the Pro23His (or P23H) mutation, is a specific change within the RHO gene. In genetic terms, this is a missense variant, meaning a single nucleotide change leads to the substitution of one amino acid for another in the resulting protein. This variant is located in the RHO gene, which provides instructions for making the rhodopsin protein. Because this variant is inherited in an autosomal dominant pattern, having a single copy of the altered gene in each cell is typically sufficient to influence the development of the associated condition. It is important to note that while this variant is well-documented in scientific literature, its presence does not guarantee a specific clinical outcome, and the expression of genetic traits can be influenced by a variety of factors.
The Role of the RHO Gene
The RHO gene is essential for human vision, as it encodes the rhodopsin protein. Rhodopsin is a light-sensitive receptor found in the rod cells of the retina, which are the specialized cells in the back of the eye responsible for vision in low-light conditions. When light hits the retina, rhodopsin initiates a chemical cascade that sends visual signals to the brain. Because this protein is critical for the initial steps of phototransduction, any structural change to the protein can disrupt the normal function or stability of rod cells. When these cells are damaged or die prematurely, it leads to the symptoms associated with retinal dystrophies, such as difficulty seeing in the dark or a gradual narrowing of the visual field over time.
Research and Clinical Associations
Research has long associated the Pro23His substitution with autosomal dominant retinitis pigmentosa (adRP). Studies have identified this variant as a recurrent mutation, particularly in North American populations. The evidence for its pathogenicity is strong in the context of clinical genetics, as it has been observed in families affected by progressive retinal degeneration. However, the clinical presentation can vary significantly between individuals, even those within the same family. While the association with retinitis pigmentosa is established, the severity and rate of vision loss can differ. Because this is a complex condition, researchers continue to study how this specific variant interacts with other genetic and environmental factors to influence the progression of retinal disease.
Population Frequency and Distribution
The rs121912528 variant is considered extremely rare on a global scale, with a minor allele frequency (MAF) typically reported as less than 0.0001 in large-scale databases like gnomAD. Despite its global rarity, it is recognized as a recurrent founder mutation in North America. This means that the variant is more common in specific populations due to historical migration and inheritance patterns rather than being evenly distributed across all ethnic groups. Because of this, the likelihood of carrying this variant depends heavily on an individual's ancestry. Genetic studies continue to refine these frequency estimates, highlighting that even rare variants can have significant impacts within specific communities or family lineages.
Interpreting Your Genetic Information
If you have received information regarding the rs121912528 variant, it is important to understand what this means in a practical sense. This information is for educational purposes and should not be used for self-diagnosis or to make medical decisions. Genetic variants are only one piece of a much larger puzzle that includes your personal health history, family history, and clinical examinations by an eye care professional. If you are concerned about your vision or have a family history of retinal disease, the most appropriate step is to consult with a genetic counselor or an ophthalmologist who specializes in inherited retinal diseases. They can provide context, discuss the implications of your specific genetic results, and guide you through appropriate clinical testing or monitoring.
How common is this variant?
The rs121912528 variant is extremely rare globally (gnomAD MAF < 0.0001), though it is recognized as a recurrent founder mutation in North American populations.
Frequently asked questions
What is the RHO gene?
The RHO gene provides instructions for making rhodopsin, a protein essential for vision in low-light conditions. It is found in the rod cells of the retina.
What is autosomal dominant retinitis pigmentosa?
It is a hereditary condition where mutations in genes like RHO lead to the progressive loss of rod photoreceptor cells. This typically results in night blindness and a gradual narrowing of the visual field.
Is the Pro23His variant common?
No, the Pro23His variant (rs121912528) is extremely rare in the general global population. However, it is known to be a recurrent founder mutation in North America.
What should I do if I have this variant?
If you are concerned about your genetic results, you should consult with a genetic counselor or an ophthalmologist. They can help you understand the clinical implications and discuss appropriate eye health monitoring.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912528?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RHO
Constitutively active rhodopsin variant (Gly90Asp) causing autosomal dominant congenital stationary night blindness (CSNB).
Encodes the Pro23His (P23H) substitution in rhodopsin, the most common autosomal dominant retinitis pigmentosa allele in North America.
A non-synonymous variant altering rhodopsin protein structure that causes autosomal dominant retinitis pigmentosa with progressive rod photoreceptor loss.
Rhodopsin missense variant (p.Pro23His) responsible for classical autosomal dominant retinitis pigmentosa with rod photoreceptor degeneration.
Classic Pro23His (p.P23H) mutation in rhodopsin causing autosomal dominant retinitis pigmentosa.
A missense substitution (p.Arg135Trp) within rhodopsin's cytoplasmic loop that causes severe autosomal dominant retinitis pigmentosa through defective phototransduction signaling.